Search research articles
Contact Us
Filters
Showing results (31-40 of 151) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2012
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Xiaojing Jia, et al.
Frontiers in Oncology
|
January 29, 2019
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Katarina K Jovanović, Guillaume Escure, Jordane Demonchy, et al.
Experimental Hematology
|
June 15, 2024
Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors
Raeeka Khamari, Claire Degand, Quentin Fovez, et al.
Blood Reviews
|
February 1, 2015
The cancer glycome: carbohydrates as mediators of metastasis
Siobhan V Glavey, Daisy Huynh, Michaela R Reagan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
High-throughput genomic analysis in Waldenström's macroglobulinemia
Stéphanie Poulain, Esteban Braggio, Christophe Roumier, et al.
Leukemia & Lymphoma
|
October 21, 2021
Smoldering multiple myeloma: biology, clinical manifestations and management
Laly Nsiala, Arthur Bobin, Anthony Levy, et al.
Blood Advances
|
April 4, 2019
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma
Ilyas Sahin, Yawara Kawano, Romanos Sklavenitis-Pistofidis, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 4, 2026
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy
Titouan Cazaubiel, Cyrille Touzeau, Laure Vincent, et al.
BMC Cancer
|
April 29, 2024
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, et al.
American Journal of Hematology
|
July 26, 2014
Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib
Ilyas Sahin, Feda Azab, Yuji Mishima, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 151) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2012
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Xiaojing Jia, et al.
Frontiers in Oncology
|
January 29, 2019
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Katarina K Jovanović, Guillaume Escure, Jordane Demonchy, et al.
Experimental Hematology
|
June 15, 2024
Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors
Raeeka Khamari, Claire Degand, Quentin Fovez, et al.
Blood Reviews
|
February 1, 2015
The cancer glycome: carbohydrates as mediators of metastasis
Siobhan V Glavey, Daisy Huynh, Michaela R Reagan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
High-throughput genomic analysis in Waldenström's macroglobulinemia
Stéphanie Poulain, Esteban Braggio, Christophe Roumier, et al.
Leukemia & Lymphoma
|
October 21, 2021
Smoldering multiple myeloma: biology, clinical manifestations and management
Laly Nsiala, Arthur Bobin, Anthony Levy, et al.
Blood Advances
|
April 4, 2019
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma
Ilyas Sahin, Yawara Kawano, Romanos Sklavenitis-Pistofidis, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 4, 2026
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy
Titouan Cazaubiel, Cyrille Touzeau, Laure Vincent, et al.
BMC Cancer
|
April 29, 2024
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, et al.
American Journal of Hematology
|
July 26, 2014
Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib
Ilyas Sahin, Feda Azab, Yuji Mishima, et al.
Page
of 16